This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Regeneron Pharmaceuticals Inc. (REGN) slid 2.73% to $636.53 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 1.90% to 4,567.00 and Dow Jones Industrial Average falling 1.86% to 34,483.72. Regeneron Pharmaceuticals Inc. closed $50.09 below its 52-week high ($686.62), which the company achieved on September 3rd.
The stock underperformed when compared to some of its competitors Tuesday, as Johnson & Johnson (JNJ) fell 2.39% to $155.93, Novartis AG ADR (NOVN.EB) fell 0.71% to $79.70, and Amgen Inc. (AMGN) fell 2.26% to $198.88. Trading volume (1.3 M) eclipsed its 50-day average volume of 753,762.
Data source: Dow Jones Market Data, FactSet. Data compiled November 30, 2021.
(END) Dow Jones Newswires
November 30, 2021 17:19 ET (22:19 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.